200 related articles for article (PubMed ID: 28225866)
1. Circulating myeloid-derived suppressor cells predict disease activity and treatment response in patients with immune thrombocytopenia.
Zhou J; Zhou Y; Wen J; Sun X; Zhang X
Braz J Med Biol Res; 2017 Feb; 50(2):e5637. PubMed ID: 28225866
[TBL] [Abstract][Full Text] [Related]
2. Distinct alterations of CD68
Shao X; Wu B; Cheng L; Li F; Zhan Y; Liu C; Ji L; Min Z; Ke Y; Sun L; Chen H; Cheng Y
J Transl Med; 2018 Mar; 16(1):48. PubMed ID: 29499727
[TBL] [Abstract][Full Text] [Related]
3. Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura.
Li J; Wang Z; Hu S; Zhao X; Cao L
Immunol Lett; 2013; 154(1-2):42-8. PubMed ID: 23994430
[TBL] [Abstract][Full Text] [Related]
4. The abnormal function of CD39
Lu Y; Cheng L; Li F; Ji L; Shao X; Wu B; Zhan Y; Liu C; Min Z; Ke Y; Sun L; Chen H; Cheng Y
Ann Hematol; 2019 Aug; 98(8):1845-1854. PubMed ID: 31154474
[TBL] [Abstract][Full Text] [Related]
5. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome.
Ling Y; Cao X; Yu Z; Ruan C
Eur J Haematol; 2007 Oct; 79(4):310-6. PubMed ID: 17692100
[TBL] [Abstract][Full Text] [Related]
6. High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia.
Hou Y; Feng Q; Xu M; Li GS; Liu XN; Sheng Z; Zhou H; Ma J; Wei Y; Sun YX; Yu YY; Qiu JH; Shao LL; Liu XG; Hou M; Peng J
Blood; 2016 Mar; 127(12):1587-97. PubMed ID: 26744458
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia.
Hou Y; Xie J; Wang S; Li D; Wang L; Wang H; Ni X; Leng S; Li G; Hou M; Peng J
Cell Mol Immunol; 2022 Jul; 19(7):764-776. PubMed ID: 35414712
[TBL] [Abstract][Full Text] [Related]
8. Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.
Hu Y; Wang X; Yu S; Hou Y; Ma D; Hou M
Expert Opin Ther Targets; 2015 Jun; 19(6):723-32. PubMed ID: 25976230
[TBL] [Abstract][Full Text] [Related]
9. High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia.
Feng Q; Xu M; Yu YY; Hou Y; Mi X; Sun YX; Ma S; Zuo XY; Shao LL; Hou M; Zhang XH; Peng J
J Thromb Haemost; 2017 Sep; 15(9):1845-1858. PubMed ID: 28682499
[TBL] [Abstract][Full Text] [Related]
10. Low-dose decitabine modulates myeloid-derived suppressor cell fitness via LKB1 in immune thrombocytopenia.
Ni X; Wang L; Wang H; Yu T; Xie J; Li G; Liu Y; Zhou H; Xu M; Hou M; Peng J; Hou Y
Blood; 2022 Dec; 140(26):2818-2834. PubMed ID: 36037415
[TBL] [Abstract][Full Text] [Related]
11. [A study of immunocyte subsets and serum cytokine profiles before and after immunal suppression treatment in patients with immune thrombocytopenia].
Li W; Wang X; Li J; Liu M; Feng J
Zhonghua Nei Ke Za Zhi; 2016 Feb; 55(2):111-5. PubMed ID: 26875579
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin receptor agonists regulate myeloid-derived suppressor cell-mediated immunomodulatory effects in ITP.
Zhu Y; Wang Y; Zhao Y; Liu D; Wang X; Zhu L; Tong J; Zhao N; Zheng C
Ann Hematol; 2024 Jun; ():. PubMed ID: 38890176
[TBL] [Abstract][Full Text] [Related]
13. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia.
Wang SC; Yang KD; Lin CY; Huang AY; Hsiao CC; Lin MT; Tsai YG
Pediatr Blood Cancer; 2020 Feb; 67(2):e28075. PubMed ID: 31736241
[TBL] [Abstract][Full Text] [Related]
15. The role of T cells and myeloid-derived suppressor cells in refractory immune thrombocytopenia.
Yazdanbakhsh K; Provan D; Semple JW
Br J Haematol; 2023 Oct; 203(1):54-61. PubMed ID: 37735552
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cells anticipate sustained treatment response in newly-diagnosed and persistent primary immune thrombocytopenia.
Elsaied DG; Noreldin NM; Saad MA; Elkhatteb MA; Esheba NE
Blood Cells Mol Dis; 2021 Mar; 87():102529. PubMed ID: 33338696
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA MEG3 inhibits microRNA-125a-5p expression and induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura.
Li JQ; Hu SY; Wang ZY; Lin J; Jian S; Dong YC; Wu XF; Dai-Lan ; Cao LJ
Biomed Pharmacother; 2016 Oct; 83():905-911. PubMed ID: 27522004
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of pregnancy-associated granulocytic myeloid-derived suppressor cell expansion and arginase-1 production in preeclampsia.
Wang Y; Liu Y; Shu C; Wan J; Shan Y; Zhi X; Sun L; Yi H; Yang YG; He J
J Reprod Immunol; 2018 Jun; 127():48-54. PubMed ID: 29763854
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived suppressor cells.
Aslam R; Burack WR; Segel GB; McVey M; Spence SA; Semple JW
Br J Haematol; 2018 Apr; 181(2):262-264. PubMed ID: 28165136
[No Abstract] [Full Text] [Related]
20. Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.
Liu B; Zhao H; Poon MC; Han Z; Gu D; Xu M; Jia H; Yang R; Han ZC
Eur J Haematol; 2007 Feb; 78(2):139-43. PubMed ID: 17328716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
